breast oncology

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

breast oncology
Dec 26, 2024, 15:50 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Here’s the most recent Breast Cancer…
Dec 19, 2024, 02:43 | Blog
Paolo Tarantino: The highly awaited Breast Cancer trials with positive results
Paolo Tarantino, PhD in clinical research at the University of Milan, shared a post on…
Dec 14, 2024, 16:05 | Blog
Stephanie Graff: First 3rd-generation HER2-directed ADC in neoadjuvant HER2+ Breast Cancer
Stephanie Graff, Director of Breast Oncology at Brown University Health and an Associate Professor of…
Dec 14, 2024, 15:44 | Blog
Sara Tolaney: First line treatment approaches in HER2+ BC
Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a…
Dec 14, 2024, 06:34 | Blog
Immediate Subsequent lines of therapy after T-DXd in Metastatic Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "SABCS24 POSTER SESSION | P1-08-08 |…
Dec 13, 2024, 06:44 | Blog
Sara Tolaney: HER3DXd showed pCR and ORR rates similar to standard multi-agent chemotherapy
Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a…
Dec 12, 2024, 15:40 | Blog
Sara Tolaney: DESTINY-Breast06 - Efficacy by pace of disease progression
Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a…
Dec 5, 2024, 11:51 | Blog
Ilana Schlam: Continuously improving breast oncology treatment algorithms
Ilana Schlam, Breast Medical Oncologist and Assistant Professor of Medicine at Tufts University Medical Center, posted…
Nov 21, 2024, 15:07 | Insight
Consumption of aspartame and the risk of Breast Cancer in the Nurses' Health Studies
Dana-Farber’s Breast Oncology Center shared a post on X: “New study in JNCI from Dana-Farber’s…
Nov 13, 2024, 23:18 | Career
Elizabeth A. Mittendorf - Candidate for President Elect for ASCO
Elizabeth A. Mittendorf has been nominated as a Candidate for ASCO President-Elect. The ASCO Nominating…
Nov 13, 2024, 08:27 | Insight
Paolo Tarantino: The promise and challenges of response-adapted trials in breast oncology
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X about a recent…
Nov 11, 2024, 13:56 | Blog
The Royal Marsden NHS Foundation Trust Offers a 2-year fellowship to conduct clinical research in cancer in older adults
Nicolò Battisti, Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust, shared a post…
Nov 10, 2024, 03:48 | Insight
Tracing 40 years of breakthroughs and challenges in ADC development
Dana-Farber’s Breast Oncology Center shared a post on X: “Don't miss this recently published Cancer…
Nov 8, 2024, 04:47 | Insight
ICIs for patients with metastatic triple-negative Inflammatory Breast Cancer
Dana-Farber’s Breast Oncology Center shared a post on X: “This just published international cohort study…
Nov 6, 2024, 14:55 | Insight
Dana Farber Cancer Institute’s 7th Annual Inflammatory Breast Cancer Patient Forum
Dana-Farber’s Breast Oncology Center shared a post on X: “Join us on Saturday November 9…
Oct 11, 2024, 13:44 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Fatima Cardoso
We are excited to introduce Dr. Fatima Cardoso, a prominent leader in breast cancer research…
Oct 9, 2024, 14:00 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Sara Tolaney
We are excited to introduce Dr. Sara Tolaney, a leading expert in breast oncology, as…
Sep 19, 2024, 12:03 | Insight
Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X: “Hot off the Press! Trastuzumab deruxtecan in HER2-positive…
Sep 10, 2024, 10:45 | Blog
Sara Tolaney: Mark your calendars for PER’s School of Breast Oncology
Sara Tolaney shared a post on X: “Mark your calendars for PER’s School of Breast…
Sep 10, 2024, 06:01 | Insight
Paolo Tarantino: A Special Collection for ADCs in Breast Oncology for Nature Portfolio
Paolo Tarantino shared on LinkedIn: "The field of ADCs is still at its dawn. Many…
Sep 5, 2024, 15:08 | Blog
Miriam Mutebi: Tips for patients navigating overwhelming sea of information
Miriam Mutebi shared a post on LinkedIn: "Yesterday morning, I came across a post on…
Sep 1, 2024, 21:58 | Blog
Monika Pansari: What Did I Do to Cause My Cancer?
Monika Pansari, Senior Consultant Surgical Oncologist (Breast and GYN Oncology), Fortis Hospital shared a post…
Aug 31, 2024, 18:55 | Blog
Miriam Mutebi: Caregivers play a vital role in the cancer care journey
Miriam Mutebi shared a post on LinkedIn: "Today I want to speak on caregivers, and how…
Aug 31, 2024, 18:36 | Blog
Asaf Maoz: Looking Back, Facing Forward is coming up September 14th
Asaf Maoz, Medical Oncologist, Dana-Farber Cancer Institute, shared a post on X: "Looking Back, Facing…
Aug 20, 2024, 16:22 | Blog
How to Get the Most Out of Your Fellowship - SSO
Society of Surgical Oncology (SSO) shared a post on X: "Join the SSO Fellows and…
Jul 26, 2024, 00:18 | Blog
Sara Tolaney on novel therapies for young women with breast cancer at Young Women's Forum
Young Women's Forum shared on X: "Honored to have Sara Tolaney, Chief of Breast Oncology…
Jul 13, 2024, 07:56 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Paolo Tarantino
Our next oncoinfluencer is Dr. Paolo Tarantino. Dr. Tarantino is active on both X/Twitter and…
Jul 6, 2024, 12:10 | Blog
Drs. Ashley Davenport and Robert Wesolowski were selected for the 2024 OSUCCC Physician Patient Champion Award - Ohio State Medical Oncology
Daniel Stover shared a post by Ohio State Medical Oncology on X, adding: .  "There…
Jun 29, 2024, 04:10 | Blog
Dana-Farber's first Young Adult patient navigator, Meghan Donovan
Dana-Farber Cancer Institute shared a post on LinkedIn: “Behind the resource desk in the new HomeGoods…
Jun 26, 2024, 03:41 | Insight
Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC
Paolo Tarantino shared a post on X:         .  "Early recurrent TNBC (Triple-Negative…
Jun 12, 2024, 03:50 | Blog
The most recent Breast Cancer Research Digest by Dana-Farber's Breast Oncology Center
Paolo Tarantino shared a post by Dana-Farber's Breast Oncology Center on X, adding the following: “Latest…
Jun 10, 2024, 02:20 | Blog
Paolo Tarantino: Great to welcome Dr. Abeid Athman for a fellowship at Dana-Farber’s Breast Oncology Center!
Paolo Tarantino shared a post on X: “Great to welcome Dr. Abeid Athman from Kenya for…
Jun 5, 2024, 10:05 | Societies
Albion Totsi: Advanced Course on Oncoplastic Breast Surgery by ESSO
Albion Totsi, General Surgeon at The Papageorgiou General Hospital of Thessaloniki, shared a post on LinkedIn: "Advanced…
Jun 1, 2024, 08:47 | Blog
Paolo Tarantino: ADCs keep shortening the distance between oncology fields
Paolo Tarantino shared a post on X: "ADCs keep shortening the distance between oncology fields.…
May 31, 2024, 15:41 | Societies
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X: "More than 25 ASCO24…
May 20, 2024, 14:22 | Blog
Nancy Lin: So fitting for a YIA to be dedicated to him and moving to see such an outpouring of support
Nancy Lin, Associate Chief of Division of Breast Oncology at Susan F. Smith Center for…
May 17, 2024, 04:08 | Blog
Dana-Farber’s Breast Oncology Center is leading a study for metastatic triple-negative Breast Cancer
Janice Cowden shared a post by Dana-Farber’s Breast Oncology Center on X/Twitter: "If you, or someone…
May 11, 2024, 12:21 | Blog
Ariana Pelosci: Cancer Network team and I visited Memorial Sloan Kettering Cancer Center to film the next installment of Breaking Barriers
Ariana Pelosci, Editor at MJH Life Sciences, shared on LinkedIn: "Yesterday the Cancer Network team…
May 8, 2024, 23:17 | Insight
Giampaolo Bianchini: Join us at the next ESMO Virtual Plenary session!
Elisa Agostinetto, Research Physician at Institute of Jules Bordet in Brussels, shared a post by Giampaolo…
May 7, 2024, 11:51 | Positive
Sara Tolaney: HAPPY NURSES WEEK!
Sara Tolaney shared a post on X: "HAPPY NURSES WEEK! A special thank you to…
Apr 28, 2024, 16:53 | Blog
Paolo Tarantino: Unmissable editorial on the current status and next steps for studying and treating brain metastases in breast oncology
Paolo Tarantino shared a post by ESMO Open, on X: "Unmissable editorial on the current status…
Apr 17, 2024, 17:38 | Insight
Paolo Tarantino: Exciting session at MLS Cleveland Clinic Congress
Paolo Tarantino, Research fellow at Dana Farber Cancer Institute, shared on X: "Exciting session at…
Apr 8, 2024, 03:54 | Drugs
Paolo Tarantino: Trastuzumab deruxtecan is now FDA approved for ANY treatment-refractory HER2+ solid tumor
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
Mar 29, 2024, 06:30 | Insight
Elisa Agostinetto: Important meta-analysis in NPJ Journals Breast shedding light on one of the biggest unmet needs in breast oncology
Elisa Agostinetto, Medical Oncologist and Research Fellow at Jules Bordet Institute in Brussels, posted on…
Nov 1, 2023, 15:01 | Societies
Isabel Rubio: Thanks to all for such an outstanding work for training and recognition
Isabel Rubio, Head of Breast Surgical Oncology at the University Hospital of Navarra, shared on…
Aug 6, 2023, 17:11 | Blog
Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year - Paolo Tarantino
With ESMO23 and SABCS23 approaching, we may soon see the results from several potentially practice-changing…
Jul 19, 2023, 18:34 | Insight
In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still at the dawn - Paolo Tarantino
In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still…
All: 47 Posts: 1 - 100
Special Coverage